1067 A three stage immune targeted immuno-cytokine platform that delivers inflammatory signals to the tumor microenvironment
Main Authors: | Brian Rabinovich, Xueyuan Zhou, Evren Alici, Jeffrey Takimoto, Nikhita Khanna, Sunny Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
An investigation of the antiplatelet effects of succinobucol (AGI-1067)
by: Stephanie A. Houston, et al.
Published: (2017-04-01) -
Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell engager
by: Xueyuan Zhou, et al.
Published: (2024-02-01) -
Reform and conquest: the penitential ordinance of John of Ivry, archbishop of Rouen (1067-1079)
by: Allen, R
Published: (2018) -
Epidemiological and clinical characteristics of breast cancer in the southern of Tunisia: about 1067 cases
by: W. Ben Kridis, et al.
Published: (2021-04-01) -
The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
by: Katharina Helene Susek, et al.
Published: (2018-09-01)